By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Corcept Therapeutics Inc. 

149 Commonwealth Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-327-3270 Fax: 650-327-3218


SEARCH JOBS


Industry
Pharmaceutical






Company News
Corcept Therapeutics Inc. (CORT) Announces First Quarter 2016 Financial Results And Provides Corporate Update 5/4/2016 12:01:10 PM
Corcept Therapeutics Inc. (CORT) To Announce First Quarter Financial Results And Corporate Update And Host Conference Call 5/2/2016 11:01:33 AM
Corcept Therapeutics Inc. (CORT) Release: Promising Pre-Clinical And Phase 1 Data Support Advance Of Selective Cortisol Modulator CORT125134 As Potential Treatment For Cushing's Syndrome And Solid-Tumor Cancers 4/29/2016 10:50:27 AM
Corcept Therapeutics Inc. (CORT) Announces 2015 Financial Results 3/2/2016 11:27:01 AM
Corcept Therapeutics Inc. (CORT) Announces Preliminary Fourth Quarter And Full Year 2015 Summary Financial Results, Provides 2016 Revenue Guidance And Corporate Update 1/29/2016 9:40:05 AM
Corcept Therapeutics Inc. (CORT) To Announce Preliminary 2015 Financial Results, Provide 2016 Revenue Guidance And Corporate Update, And Host Conference Call 1/22/2016 10:24:22 AM
Corcept Therapeutics Inc. (CORT) Announces Initial Efficacy Results In Phase 1/2 Trial Of Mifepristone In Combination With Eribulin For The Treatment Of Patients With Metastatic Triple-Negative Breast Cancer 12/15/2015 12:08:57 PM
Corcept Therapeutics Inc. (CORT) Announces Third Quarter 2015 Results And Provides Corporate Update 11/9/2015 2:41:29 PM
Corcept Therapeutics Inc. (CORT) To Announce Third Quarter Financial Results And Corporate Update And Host Conference Call 10/30/2015 12:50:52 PM
Corcept Therapeutics Inc. (CORT) Release: Results Of Phase 1 Trial Of Next-Generation Cortisol Modulator CORT125134 To Be Presented At Annual Meeting Of American Association of Pharmaceutical Scientists 10/14/2015 1:50:43 PM
12345678910...
//-->